Kalos Management, Inc. Novo Nordisk A S Transaction History

Kalos Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $3.07 Million - $3.5 Million	-69,363 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$48.49 - $58.14 $46,938 - $56,279	968 Added 1.42%	69,363 $3.42 Million
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $39,259 - $44,380	-826 Reduced 1.19%	68,395 $3.67 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $85,592 - $102,377	2,080 Added 3.1%	69,221 $3.33 Million
Q2 2017 Aug 15, 2017	BUY	N/A	67,141	67,141 $2.88 Million

1,881

336M

11.9M

10.6M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $199B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.